Proton Therapy Shows Survival Benefit Over Photon Radiotherapy in Advanced Oropharyngeal Cancer: Phase 3 Trial Written By Medha Baranwal28 Dec 2025 8:15 PM ISTUSA: A large US-based phase III clinical trial has shown that proton radiotherapy offers a meaningful survival advantage and reduced toxicity compared...
Higher Lycopene Intake Linked to Nearly 50 Percent Lower Prostate Cancer Risk: Study Written By Medha Baranwal26 Dec 2025 8:15 PM ISTSpain: A new analysis from the PREDIMED cohort has shed light on the potential protective role of lycopene-rich diets in reducing prostate cancer risk...
2 Years of Treatment, 7 Years of Benefits: Abemaciclib Delivers New Overall Survival Data in Breast Cancer Patients Written By Medical Dialogues Team26 Dec 2025 11:45 AM ISTIn this short video, Dr Nitesh Rohtagi, Principal Director, Department of Medical Oncology, Fortis Cancer Institute, Delhi and Gurugram, discusses...
Night shifts aren't just tiring, they can be deadly, suggests study Written By Dr. Kamal Kant Kohli25 Dec 2025 8:30 PM ISTWorking the night shift, frequently flying across time zones or keeping an irregular sleep schedule does more than just leave us exhausted; it can...
Adding antibody treatment to chemo boosts outcomes for children with rare cancer: Study Written By Dr. Kamal Kant Kohli25 Dec 2025 8:00 PM ISTChildren with a rare form of cancer called neuroblastoma which hasn't responded to initial treatment or that has relapsed may benefit from adding...
Routine scans could detect early prostate radiotherapy changes, suggests study Written By Dr. Kamal Kant Kohli24 Dec 2025 8:30 PM ISTDaily scans taken during prostate cancer radiotherapy could be repurposed to guide changes to treatment, reducing the risk of side effects, a study...
Low daily alcohol intake linked to 50% heightened mouth cancer risk in India, suggests research Written By Dr. Kamal Kant Kohli24 Dec 2025 10:15 AM ISTEven a low daily intake of alcohol-just 9 g or around one standard drink-is linked to a 50% heightened risk of mouth (buccal mucosa) cancer in India,...
ESMO 2025 Update: Effect of Abemaciclib added to standard Endocrine Therapy in High-Risk Early Breast Cancer Written By Medical Dialogues Team23 Dec 2025 11:30 AM ISTAdjuvant abemaciclib combined with endocrine therapy (ET) has demonstrated a statistically significant and clinically meaningful improvement in...
Five-Day Preoperative Radiation Shows Promise for High-Risk Soft Tissue Sarcoma: Study Written By Medha Baranwal22 Dec 2025 9:15 PM ISTUSA: A shortened five-day course of preoperative radiation therapy may offer a more convenient yet effective alternative to the conventional five-week...
SABCS: Novel endocrine therapy reduces the risk of breast cancer recurrence Written By Dr. Kamal Kant Kohli22 Dec 2025 5:30 AM ISTIn an international study led by UCLA, researchers have shown that giredestrant, a next-generation oral selective estrogen receptor antagonist and...
UDCA Use in Primary Biliary Cholangitis Associated With Reduced Cancer Risk: JAMA Written By Medha Baranwal21 Dec 2025 9:00 PM ISTUSA: A large retrospective, propensity score-matched cohort study found that ursodeoxycholic acid (UDCA) use in patients with primary biliary...
What are Key Predictors of Bleeding Risk with Long-Term Apixaban in Cancer-Associated VTE? Written By Dr Riya Dave20 Dec 2025 6:45 AM ISTAccording to a new study, among patients receiving extended anticoagulation with apixaban for cancer-associated VTE, four predictors of clinically...
